Forward Pharma A/S announced that its board of directors has appointed Claus Bo Svendsen as chief executive officer, effective March 1, 2017. He previously held the position of executive vice president at the company. Dr. Svendsen succeeds Peder M. Andersen, M.D., who has led the company since 2012.

Dr. Andersen will retain his role as chief operating officer and serve until September 1, 2017. Dr. Svendsen joined the Company in 2015, prior to which he held positions of increasing seniority in the Danish pharmaceutical company, Novo Nordisk A/S, with his last role being global medical director. Previously, Dr. Svendsen worked in biotech venture capital and has a clinical background in internal medicine.